News Summary

• Georgia Witchel's Mantis Biotech makes Parva, consumer software that reads how a person types and clicks to flag cognitive change relative to their own baseline.
• The approach targets conditions that shift daily and disproportionately affect women.
• Backed by $7.4 million led by Decibel, Parva reaches patients through ADHD, psychiatry, perimenopause, and neurology clinics.
• Pending FDA clearance, it flags risk rather than diagnosing, offering a continuous record where medicine was once measured by feel.